Journal List > Yonsei Med J > v.52(3) > 1030828

TOOLS
Kim and Yang: Retraction: Human Papillomavirus Type 16 E5 Protein as a Therapeutic Target. Yonsei Med J 2006;47(1):1-14
Retraction
Yonsei Medical Journal

Yonsei Medical Journal 2011; 52(3): 551.

Published online: 6 April 2011

DOI: https://doi.org/10.3349/ymj.2011.52.3.551

Retraction: Human Papillomavirus Type 16 E5 Protein as a Therapeutic Target. Yonsei Med J 2006;47(1):1-14

Sang-Woo Kim, Joo-Sung Yang

Department of Genetic Engineering, Faculty of Life Science and Technology, Sungkyunkwan University, Suwon, Korea.

© Copyright: Yonsei University College of Medicine 2011

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
To the Editor
I deeply regret to inform you and request for retraction of our review paper published in YMJ.1
We have applied for the U.S. patent with some ideas and research data which are related to the review paper. Upon request from a patent lawyer's office, we checked the references used in our paper for the Information Disclosure Statement (IDS). We realized that our review paper plagiarized several sentences from a previously published review paper titled as "The biochemical and biological functions of human papillomavirus type 16 E5 protein" in Arch Virol (2003;148:1445-53). As a corresponding author, I will take full responsibility and respectfully request for the retraction of our review paper from YMJ.

References

1. Kim SW, Yang JS. Human papillomavirus type 16 E5 protein as a therapeutic target. Yonsei Med J. 2006. 47(1):1–14.
crossref
TOOLS
Similar articles